Open AccessA Randomized Controlled Trial to Assess the Efficacy of Tiotropium in Canadian Patients with Chronic Obstructive Pulmonary Disease
Author(s) -
Charles K.N. Chan,
François Maltais,
Chris Sigouin,
Jennifer Haddon,
Gordon Ford,
on behalf of the SAFE Study Group
Publication year - 2007
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2007/192961
Subject(s) - medicine , pulmonary disease , randomized controlled trial , tiotropium bromide , copd , intensive care medicine , physical therapy , lung function , lung
Patients with chronic obstructive pulmonary disease (COPD) who smoke have a greater annual rate of decline in forced expiratory volume in 1 s (FEV(1)) than those patients who have stopped smoking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom